Kishimoto T, Hirai Y, Nakanishi K, Azuma I, Nagamatsu A, Yamamura Y
J Immunol. 1979 Dec;123(6):2709-15.
The suppressive effect of antigen-conjugated muramylpeptides or 6-O-mycoloyl muramylpeptides selectively on the induction of IgE antibody response was demonstrated. Preadministration of DNP-mycoloyl muramylpeptides completely inhibited the induction of the anti-DNP IgE antibody response with DNP-ovalbumin (DNP-OA). The selective suppression of the IgE response was due to the induction of DNP-specific suppressor T cells by DNP-mycoloyl muramylpeptides, and the suppressor cells were shown to be radiosensitive. Preadministration of OA-conjugated muramylpeptides partially inhibited the primary and secondary induction of an anti-OA IgE antibody response. The suppressor effect was also due to the induction of OA-specific suppressor T cells. Application of allergen-conjugated muramylpeptides as therapeutic agents in human allergic diseases was suggested.
已证实抗原结合的胞壁酰肽或6 - O - 分枝菌酰胞壁酰肽对IgE抗体应答诱导具有选择性抑制作用。预先给予二硝基苯基(DNP)- 分枝菌酰胞壁酰肽可完全抑制用DNP - 卵清蛋白(DNP - OA)诱导的抗DNP IgE抗体应答。IgE应答的选择性抑制是由于DNP - 分枝菌酰胞壁酰肽诱导了DNP特异性抑制性T细胞,且这些抑制性细胞对辐射敏感。预先给予卵清蛋白(OA)结合的胞壁酰肽可部分抑制抗OA IgE抗体应答的初次和再次诱导。这种抑制作用同样是由于诱导了OA特异性抑制性T细胞。有人提出将变应原结合的胞壁酰肽用作人类过敏性疾病的治疗药物。